Common Stock SEC Reporting - Current
Verified Company Profile 9/15/2016
Contact Info
  • 4203 SW 34th St
  • Orlando, FL 32811

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0000075439
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 1999
Employees 77 a/o Sep 01, 2016
Company Officers/Contacts
Michaela Ott President, CEO
Robert McCullough, Jr. CFO
Company Directors
John Abeles
W. Austin Lewis IV
Robert McCullough, Jr.
Augusto Ocana
Company Notes
  • Formerly=CytoCore, Inc. until 12-2014
  • Formerly=Molecular Diagnostics, Inc. until 8-06
  • Formerly=Ampersand Medical Corp. until 9-01
  • Note=5-99 State of incorporation California changed to Delaware
  • Formerly=Bell National Corp. until 5-99
  • Formerly=Pacific Coast Holdings, Inc. to 1-83
  • Note=8-85 Company filed petition under Chapter XI of the Federal Bankruptcy Act.
Service Providers
Accounting/Auditing Firm
Withum Brown & Smith
180 S. Orange #1150
Suite 1150
Orlando, FL, 32801
United States

Legal Counsel
O'Neal Law Firm
17100 E. Shea Blvd.
Suite 400-D
Fountain Hills, AZ, 85268
United States

Investor Relations Firm
Not Available
MDIT Security Details
Share Structure
Market Value1 $11,166,386 a/o Oct 26, 2016
Authorized Shares 35,000,000 a/o Sep 13, 2016
Outstanding Shares 21,269,307 a/o Sep 13, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders of Record 536 a/o Sep 13, 2016
Short Selling Data
Short Interest 0 (-100%)
Aug 31, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security